Sharareh Gholamin - Publications

Affiliations: 
2012-2017 Neurosurgery Stanford University School of Medicine, Palo Alto, CA, United States 
Website:
https://www.parkerici.org/person/sharareh-gholamin-phd/

20/52 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Gholamin S, Youssef OA, Rafat M, Esparza R, Kahn S, Shahin M, Giaccia AJ, Graves EE, Weissman I, Mitra S, Cheshier SH. Irradiation or temozolomide chemotherapy enhances anti-CD47 treatment of glioblastoma. Innate Immunity. 1753425919876690. PMID 31547758 DOI: 10.1177/1753425919876690  1
2019 Hutter G, Theruvath J, Graef CM, Zhang M, Schoen MK, Manz EM, Bennett ML, Olson A, Azad TD, Sinha R, Chan C, Assad Kahn S, Gholamin S, Wilson C, Grant G, et al. Microglia are effector cells of CD47-SIRPα antiphagocytic axis disruption against glioblastoma. Proceedings of the National Academy of Sciences of the United States of America. PMID 30602457 DOI: 10.1073/pnas.1721434116  1
2018 Kahn SA, Wang X, Nitta RT, Gholamin S, Theruvath J, Hutter G, Azad TD, Wadi L, Bolin S, Ramaswamy V, Esparza R, Liu KW, Edwards M, Swartling FJ, Sahoo D, et al. Publisher Correction: Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastoma. Nature Communications. 9: 4651. PMID 30389946 DOI: 10.1038/s41467-018-07182-1  1
2018 Kahn SA, Wang X, Nitta RT, Gholamin S, Theruvath J, Hutter G, Azad TD, Wadi L, Bolin S, Ramaswamy V, Esparza R, Liu KW, Edwards M, Swartling FJ, Sahoo D, et al. Notch1 regulates the initiation of metastasis and self-renewal of Group 3 medulloblastoma. Nature Communications. 9: 4121. PMID 30297829 DOI: 10.1038/s41467-018-06564-9  1
2018 Purzner T, Purzner J, Buckstaff T, Cozza G, Gholamin S, Rusert JM, Hartl TA, Sanders J, Conley N, Ge X, Langan M, Ramaswamy V, Ellis L, Litzenburger U, Bolin S, et al. Developmental phosphoproteomics identifies the kinase CK2 as a driver of Hedgehog signaling and a therapeutic target in medulloblastoma. Science Signaling. 11. PMID 30206138 DOI: 10.1126/scisignal.aau5147  0.4
2017 Gholamin S, Mitra SS, Feroze AH, Liu J, Kahn SA, Zhang M, Esparza R, Richard C, Ramaswamy V, Remke M, Volkmer AK, Willingham S, Ponnuswami A, McCarty A, Lovelace P, et al. Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors. Science Translational Medicine. 9. PMID 28298418 DOI: 10.1126/scitranslmed.aaf2968  1
2017 Chang J, Mancuso MR, Maier C, Liang X, Yuki K, Yang L, Kwong JW, Wang J, Rao V, Vallon M, Kosinski C, Zhang JJ, Mah AT, Xu L, Li L, ... Gholamin S, et al. Gpr124 is essential for blood-brain barrier integrity in central nervous system disease. Nature Medicine. PMID 28288111 DOI: 10.1038/nm.4309  0.4
2016 Assad Kahn S, Costa SL, Gholamin S, Nitta RT, Dubois LG, Fève M, Zeniou M, Coelho PL, El-Habr E, Cadusseau J, Varlet P, Mitra SS, Devaux B, Kilhoffer MC, Cheshier SH, et al. The anti-hypertensive drug prazosin inhibits glioblastoma growth via the PKCδ-dependent inhibition of the AKT pathway. Embo Molecular Medicine. 8: 511-526. PMID 27138566 DOI: 10.15252/emmm.201505421  1
2016 Zhang M, Hutter G, Kahn SA, Azad TD, Gholamin S, Xu CY, Liu J, Achrol AS, Richard C, Sommerkamp P, Schoen MK, McCracken MN, Majeti R, Weissman I, Mitra SS, et al. Anti-CD47 Treatment Stimulates Phagocytosis of Glioblastoma by M1 and M2 Polarized Macrophages and Promotes M1 Polarized Macrophages In Vivo. Plos One. 11: e0153550. PMID 27092773 DOI: 10.1371/journal.pone.0153550  1
2016 Razavi SM, Lee KE, Jin BE, Aujla PS, Gholamin S, Li G. Immune Evasion Strategies of Glioblastoma. Frontiers in Surgery. 3: 11. PMID 26973839 DOI: 10.3389/fsurg.2016.00011  0.4
2016 Yousefi M, Mozafari N, Hosseini MS, Gholamin S, Razavi SM, Namazi MR, Younespour S. Evaluating serum prolactin and serum dehydroepiandrosterone sulfate levels in patients with pemphigus. International Journal of Dermatology. 55: e332-7. PMID 26910580 DOI: 10.1111/ijd.13199  1
2015 Mirzaei H, Gholamin S, Shahidsales S, Sahebkar A, Jafaari MR, Mirzaei HR, Hassanian SM, Avan A. MicroRNAs as potential diagnostic and prognostic biomarkers in melanoma. European Journal of Cancer (Oxford, England : 1990). 53: 25-32. PMID 26693896 DOI: 10.1016/j.ejca.2015.10.009  1
2015 Gholamin S, Pasdar A, Khorrami MS, Mirzaei H, Mirzaei HR, Salehi R, Ferns GA, Ghayour-Mobarhan M, Avan A. The potential for circulating microRNAs in the diagnosis of myocardial infarction: a novel approach to disease diagnosis and treatment. Current Pharmaceutical Design. PMID 26561061  1
2015 Mitra SS, Feroze AH, Gholamin S, Richard C, Esparza R, Zhang M, Azad TD, Alrfaei B, Kahn SA, Hutter G, Guzman R, Creasey GH, Plant GW, Weissman IL, Edwards MS, et al. Neural Placode Tissue Derived From Myelomeningocele Repair Serves as a Viable Source of Oligodendrocyte Progenitor Cells. Neurosurgery. PMID 26225855 DOI: 10.1227/NEU.0000000000000918  1
2015 Bui TT, Nitta RT, Kahn SA, Razavi SM, Agarwal M, Aujla P, Gholamin S, Recht L, Li G. γ-Glutamyl transferase 7 is a novel regulator of glioblastoma growth. Bmc Cancer. 15: 225. PMID 25884624 DOI: 10.1186/s12885-015-1232-y  1
2015 Nitta RT, Gholamin S, Feroze AH, Agarwal M, Cheshier SH, Mitra SS, Li G. Casein kinase 2α regulates glioblastoma brain tumor-initiating cell growth through the β-catenin pathway. Oncogene. 34: 3688-99. PMID 25241897 DOI: 10.1038/onc.2014.299  1
2014 Tang Y, Gholamin S, Schubert S, Willardson MI, Lee A, Bandopadhayay P, Bergthold G, Masoud S, Nguyen B, Vue N, Balansay B, Yu F, Oh S, Woo P, Chen S, et al. Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition. Nature Medicine. 20: 732-40. PMID 24973920 DOI: 10.1038/nm.3613  1
2014 Bandopadhayay P, Bergthold G, Nguyen B, Schubert S, Gholamin S, Tang Y, Bolin S, Schumacher SE, Zeid R, Masoud S, Yu F, Vue N, Gibson WJ, Paolella BR, Mitra SS, et al. BET bromodomain inhibition of MYC-amplified medulloblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 912-25. PMID 24297863 DOI: 10.1158/1078-0432.CCR-13-2281  1
2012 Tavana S, Argani H, Gholamin S, Razavi SM, Keshtkar-Jahromi M, Talebian AS, Moghaddam KG, Sepehri Z, Azad TM. Influenza vaccination in patients with pulmonary sarcoidosis: Efficacy and safety Influenza and Other Respiratory Viruses. 6: 136-141. PMID 21955954 DOI: 10.1111/j.1750-2659.2011.00290.x  1
2010 Keshtkar-Jahromi M, Boroumand M, Razavi SM, Gholamin S, Haghighat B, Hashemi MJ, Khani M, Naghili B. Brucella endocarditis, a report of 14 cases (1991-2009) Journal of Infection. 61: 89-92. PMID 20362000 DOI: 10.1016/j.jinf.2010.03.027  1
Low-probability matches
2018 Gholamin S, Mirzaei H, Razavi SM, Hassanian SM, Saadatpour L, Masoudifar A, ShahidSales S, Avan A. GD2-targeted immunotherapy and potential value of circulating microRNAs in neuroblastoma. Journal of Cellular Physiology. 233: 866-879. PMID 28145567 DOI: 10.1002/jcp.25793  0.04
2017 Dos Santos Cavalcanti A, Meohas W, Ribeiro GO, de Sá Lopes AC, Gholamin S, Razavi M, Hanae Kasai Brunswick T, Avan A, Matheus Guimarães JA, Leite Duarte ME, Kahn SA. Patient-derived osteosarcoma cells are resistant to methotrexate. Plos One. 12: e0184891. PMID 28934267 DOI: 10.1371/journal.pone.0184891  0.04
2014 Gholamin S, Razavi SM, Taghavi-Garmestani SM, Ghorbanihaghjo A, Rashtchizadeh N, Safa J, Vatankhah AM, Azizi T, Argani H. Lovastatin for reduction of leptin in nondialysis patients with type 2 diabetic nephropathy. Iranian Journal of Kidney Diseases. 8: 201-6. PMID 24878942  0.04
2013 Razavi SM, Gholamin S, Eskandari A, Mohsenian N, Ghorbanihaghjo A, Delazar A, Rashtchizadeh N, Keshtkar-Jahromi M, Argani H. Red grape seed extract improves lipid profiles and decreases oxidized low-density lipoprotein in patients with mild hyperlipidemia. Journal of Medicinal Food. 16: 255-8. PMID 23437789 DOI: 10.1089/jmf.2012.2408  0.04
2012 Keshtkar-Jahromi M, Razavi SM, Gholamin S, Keshtkar-Jahromi M, Hossain M, Sajadi MM. Medical versus medical and surgical treatment for brucella endocarditis. The Annals of Thoracic Surgery. 94: 2141-6. PMID 23102495 DOI: 10.1016/j.athoracsur.2012.07.006  0.04
2009 Keshtkar-Jahromi M, Vakili H, Rahnavardi M, Gholamin S, Razavi SM, Eskandari A, Sadeghi R, Vatan-Pour H, Keshtkar-Jahromi M, Haghighat B, Ghaffaripour M, Mokhtari-Azad T. Antibody response to influenza immunization in coronary artery disease patients: a controlled trial. Vaccine. 28: 110-3. PMID 19819210 DOI: 10.1016/j.vaccine.2009.09.108  0.04
2017 Gholamin S, Esparza R, Cheshier S, Mitra S. TRTH-32. COMBINATION IMMUNOTHERAPY TO ACTIVATE THE INNATE IMMUNE MICROENVIRONMENT AGAINST PEDIATRIC BRAIN TUMORS Neuro-Oncology. 19: iv58-iv59. DOI: 10.1093/neuonc/nox083.242  0.01
2017 Gholamin S, Kahn S, Esparza R, Weissman I, Mitra S, Cheshier S. IMMU-18. HUMANIZED ANTI-CD47 ANTIBODY COMBINED WITH AN AGONIST ANTI-CD40 ANTIBODY IS AN EFFECTIVE TREATMENT FOR DIPG XENOGRAFTS WITH CRANIOSPINAL DISSEMINATION Neuro-Oncology. 19: iv31-iv31. DOI: 10.1093/neuonc/nox083.128  0.01
2017 Hutter G, Theruvath JL, Kahn SA, Graef CM, Schoen MK, Gholamin S, Manz EM, Weissman IL, Mitra SS, Cheshier SH. OS01.4 Induction of differential macrophage and microglial glioblastoma phagocytosis by anti CD47 treatment - implication of tumor subtypes Neuro-Oncology. 19: iii1-iii2. DOI: 10.1093/neuonc/nox036.003  0.01
2017 Mitra SS, Gholamin S. OS01.1 Identification of the pre-malignant cell of origin in Human Glioblastoma Multiforme Neuro-Oncology. 19: iii1-iii1. DOI: 10.1093/neuonc/nox036.000  0.01
2016 ShahidSales S, Hassanian SM, Mahdavian Zadeh R, Ghayour-Mobarhan M, Gholamin S, Ferns GA, Avan A. Role of SFRP1 in NPC Metastasis-Letter. Cancer Prevention Research (Philadelphia, Pa.). 9: 415. PMID 26880740 DOI: 10.1158/1940-6207.CAPR-15-0364  0.01
2016 Kahn SA, Wang X, Nitta R, Gholamin S, Ramaswamy V, Azad T, Sahoo D, Esparza R, Chu P, Fisher P, Vogel H, Li G, Cho Y, Taylor M, Mitra S, et al. MB-16NOTCH1 PROMOTES GROUP 3 MEDULLOBLASTOMA METASTASIS, INITIATION AND SELF-RENEWAL Neuro-Oncology. 18: iii100.1-iii100. DOI: 10.1093/neuonc/now076.14  0.01
2016 Mitra S, Gholamin S, Feroze A, Weissman I, Cheshier S. HG-98IDENTIFICATION OF THE PRE-MALIGNANT CELL OF ORIGIN IN PEDIATRIC GLIOBLASTOMA MULTIFORME Neuro-Oncology. 18: iii71.2-iii71. DOI: 10.1093/neuonc/now073.94  0.01
2015 ShahidSales S, Mobarhan MG, Ghasemi F, Gholamin S, Avan A. Low expression of chloride channel accessory 1 predicts a poor prognosis in colorectal cancer: The question is still open. Cancer. 121: 3922-3. PMID 26218330 DOI: 10.1002/cncr.29598  0.01
2015 Avan A, Avan A, Maftouh M, Ghayour Mobarhan M, Shahidsales S, Gholamin S. Biomarker Analysis in CLEOPATRA: Searching for a Sensitive Prognostic Factor in Breast Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 33: 1711-2. PMID 25870088 DOI: 10.1200/JCO.2014.60.4702  0.01
2015 Avan A, Avan A, Maftouh M, Mobarhan MG, Gholamin S. Pharmacogenomic modeling in pancreatic cancer—letter. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 1497. PMID 25770295 DOI: 10.1158/1078-0432.CCR-14-2951  0.01
2015 Gholamin S, Mitra S, Esparza R, Liu J, Feroze A, Cho YJ, Zhang M, Vogel H, Edwards M, Weissman I, Cheshier S. IMPS-26HARNESSING THE MYELOID CHECKPOINT CD47-SIRPa AXIS AGAINST ADULT AND PEDIATRIC MALIGNANT BRAIN TUMORS: A NOVEL IMMUNOTHERAPEUTIC MODALITY Neuro-Oncology. 17: v118.4-v118. DOI: 10.1093/neuonc/nov217.25  0.01
2015 Kahn S, Nitta R, Wang K, Gholamin S, Azad T, Zhang M, Cho Y, Taylor M, Mitra S, Weissman I, Cheshier S. MB-01 * NOTCH1 PROMOTES MYC MEDULLOBLASTOMA METASTASIS, INITIATION AND MAINTENANCE Neuro-Oncology. 17: iii19-iii20. DOI: 10.1093/neuonc/nov061.77  0.01
2015 Gholamin S, Kahn SA, Esparza R, Hutter G, Feroze A, Weissman IL, Mitra SS, Cheshier SH. PM-08 * A HUMANIZED CO-TRANSPLANT XENOGRAFT MOUSE MODEL, TO STUDY TOXICITY OF DRUGS TARGETED AGAINST PEDIATRIC BRAIN TUMORS Neuro-Oncology. 17: iii32-iii32. DOI: 10.1093/neuonc/nov061.130  0.01
2014 Gholamin S, Fiuji H, Maftouh M, Mirhafez R, Shandiz FH, Avan A. Targeting c-MET/HGF signaling pathway in upper gastrointestinal cancers: rationale and progress. Current Drug Targets. 15: 1302-11. PMID 25382190  0.01
2014 Feroze A, Lee K, Alrfaei B, Gholamin S, Azad T, Mitra S, Lu B, Cheshier S. CS-07 * mTORC2/Akt SIGNALING IS MODULATED BY NONCANONICAL MITOCHONDRIAL NOTCH-PINK1 INTERACTION IN MEDULLOBLASTOMA (GROUP III) TUMORIGENESIS Neuro-Oncology. 16: v52-v52. DOI: 10.1093/neuonc/nou242.7  0.01
2014 Cho Y, Tang Y, Schubert S, Willardson M, Bandopadhayay P, Bergthold G, Nguyen B, Masoud S, Vue N, Balansay B, Gholamin S, Cheshier SH, Atwood SX, Whitson RJ, Lee A, et al. EPIGENETIC TARGETING OF HEDGEHOG PATHWAY TRANSCRIPTIONAL OUTPUT Neuro-Oncology. 16: iii25-iii25. DOI: 10.1093/neuonc/nou208.9  0.01
2013 Adachi K, Sasaki H, Nagahisa S, Yoshida K, Hattori N, Nishiyama Y, Kawase T, Hasegawa M, Abe M, Hirose Y, Alentorn A, Marie Y, Poggioli S, Alshehhi H, Boisselier B, ... ... Gholamin S, et al. OMICS AND PROGNSTIC MARKERS Neuro-Oncology. 15: iii136-iii155. DOI: 10.1093/neuonc/not183  0.01
2013 Campian J, Gladstone D, Ambady P, Ye X, King K, Borrello I, Petrik S, Golightly M, Holdhoff M, Grossman S, Bhardwaj R, Chakravadhanula M, Ozols V, Georges J, Carlson E, ... ... Gholamin S, et al. IMMUNOTHERAPY/BIOLOGICAL THERAPIES Neuro-Oncology. 15: iii68-iii74. DOI: 10.1093/neuonc/not178  0.01
2013 Agarwal M, Nitta R, Dovat S, Li G, Arita H, Narita Y, Fukushima S, Tateishi K, Matsushita Y, Yoshida A, Miyakita Y, Ohno M, Collins VP, Kawahara N, Shibui S, ... ... Gholamin S, et al. CELL BIOLOGY AND SIGNALING Neuro-Oncology. 15: iii12-iii31. DOI: 10.1093/neuonc/not174  0.01
2012 Banks L, Gholamin S, White E, Zijenah L, Katzenstein DA. Comparing Peripheral Blood Mononuclear Cell DNA and Circulating Plasma viral RNA pol Genotypes of Subtype C HIV-1. Journal of Aids & Clinical Research. 3: 141-147. PMID 23019537  0.01
2011 Abbasi F, Yadegarynia D, Keshtkar-Jahromi M, Gholamin S. PP-199 Adrenal insufficiency due to tuberculosis in a young man International Journal of Infectious Diseases. 15: S100. DOI: 10.1016/S1201-9712(11)60349-4  0.01
2011 Abbasi F, Yadegarynia D, Gholamin S, Korooni S, Razavi M. PP-071 Encephalitis due influenza A (H1N1) in a seven year-old girl with good response to oseltamivir International Journal of Infectious Diseases. 15: S65. DOI: 10.1016/S1201-9712(11)60224-5  0.01
2011 Abbasi F, Mardani M, Yadegarynia D, Aghahasani M, Korooni S, Gholamin S. PP-062 Mucormycosis: clinical manifestation, diagnosis and management study of nine cases International Journal of Infectious Diseases. 15: S62-S63. DOI: 10.1016/S1201-9712(11)60215-4  0.01
2010 Fahimi H, Faridi M, Gholamin S, Gholamin S, Molanaee S, Molanaee S, Khorsandi M. Cystic lymphangioma of the pancreas: diagnostic and therapeutic challenges. Jop : Journal of the Pancreas. 11: 617-9. PMID 21068498  0.01
2010 Abbasi F, Yadegarynia D, Mardani M, Frasinejad B, Yaghubi T, Gholamin S. Emerging multi drug-resistant Acinetobacter in Iran: Study of 800 cases International Journal of Infectious Diseases. 14: e36. DOI: 10.1016/J.IJID.2010.02.1567  0.01
2009 Abbasi F, Yadegarynia D, Fardkhani SK, Gholamin S. P232 Tuberculosous otitis media in a young woman International Journal of Antimicrobial Agents. 34: S100. DOI: 10.1016/S0924-8579(09)70451-0  0.01
Hide low-probability matches.